800 343 7475
ir@bio-techne.com
bio-techne.com
Overview
News / Events
Company Information
Strategy
Financial Information
Stock Data
SEC Filings
Corporate Governance
Navigation
SEC Filings
Overview
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Profile
Presentations
Management Team
Contacts
FAQ
Financial Info
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Annual Reports
Stock Data
Overview
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
10-K Filings
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
All SEC Filings
SEC Filings
Overview
All SEC Filings
10-K Filings
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
5
8-K
8-K/A
ARS
CORRESP
DEF 14A
DEFA14A
NT 10-K
NT 10-Q
POS AM
PRE 14A
S-3
S-8
SC 13D/A
SC 13G
SC 13G/A
SD
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Date
Form
Description
PDF
XBRL
Pages
05/13/03
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-99
17
05/01/03
8-K
Current report filing
Documents
EX-99
5
02/14/03
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
02/13/03
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-10.1
EX-99
22
02/12/03
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
01/22/03
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
11/22/02
8-K
Current report filing
Documents
EX-16
3
11/13/02
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-99
14
09/27/02
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-10.39
EX-11
EX-23
EX-99
45
09/23/02
DEF 14A
Definitive proxy statements
13
102
103
104
105
106
107
108
109
110
111
Email Alerts
Contacts
RSS News Feed